Keros Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Keros Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2020 to Q2 2024.
  • Keros Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 1.91K %, a 7.29% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 1.91K -150 -7.29% Jun 30, 2024
Q1 2024 1.91K +17.2 +0.91% Mar 31, 2024
Q4 2023 1.86K +70.7 +3.96% Dec 31, 2023
Q3 2023 1.99K +102 +5.4% Sep 30, 2023
Q2 2023 2.06K +196 +10.5% Jun 30, 2023
Q1 2023 1.89K -368 -16.3% Mar 31, 2023
Q4 2022 1.79K -692 -27.9% Dec 31, 2022
Q3 2022 1.88K -974 -34.1% Sep 30, 2022
Q2 2022 1.86K -1.09K -37% Jun 30, 2022
Q1 2022 2.26K -327 -12.6% Mar 31, 2022
Q4 2021 2.48K +515 +26.3% Dec 31, 2021
Q3 2021 2.86K +1.62K +131% Sep 30, 2021
Q2 2021 2.96K Jun 30, 2021
Q1 2021 2.59K Mar 31, 2021
Q4 2020 1.96K Dec 31, 2020
Q3 2020 1.24K Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.